These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28467603)

  • 1. Pathophysiology and therapeutics of premature ageing in chronic kidney disease, with a focus on glycative stress.
    Hirakawa Y; Jao TM; Inagi R
    Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():70-77. PubMed ID: 28467603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis.
    Hirakawa Y; Inagi R
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAGE and glyoxalase in kidney disease.
    Inagi R
    Glycoconj J; 2016 Aug; 33(4):619-26. PubMed ID: 27270765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products in the pathogenesis of chronic kidney disease.
    Rabbani N; Thornalley PJ
    Kidney Int; 2018 Apr; 93(4):803-813. PubMed ID: 29477239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and Premature Ageing in Chronic Kidney Disease.
    Ebert T; Pawelzik SC; Witasp A; Arefin S; Hobson S; Kublickiene K; Shiels PG; Bäck M; Stenvinkel P
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics.
    Rabbani N; Xue M; Thornalley PJ
    Glycoconj J; 2016 Aug; 33(4):513-25. PubMed ID: 27406712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Glyoxalase System in Age-Related Diseases: Nutritional Intervention as Anti-Ageing Strategy.
    Aragonès G; Rowan S; Francisco SG; Whitcomb EA; Yang W; Perini-Villanueva G; Schalkwijk CG; Taylor A; Bejarano E
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentoxifylline mitigates renal glycoxidative stress in obese mice by inhibiting AGE/RAGE signaling and increasing glyoxalase levels.
    Inacio MD; Costa MC; Lima TFO; Figueiredo ID; Motta BP; Spolidorio LC; Assis RP; Brunetti IL; Baviera AM
    Life Sci; 2020 Oct; 258():118196. PubMed ID: 32763295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hesperetin ameliorates diabetic nephropathy in rats by activating Nrf2/ARE/glyoxalase 1 pathway.
    Chen YJ; Kong L; Tang ZZ; Zhang YM; Liu Y; Wang TY; Liu YW
    Biomed Pharmacother; 2019 Mar; 111():1166-1175. PubMed ID: 30841430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging.
    Vlassara H; Torreggiani M; Post JB; Zheng F; Uribarri J; Striker GE
    Kidney Int Suppl; 2009 Dec; (114):S3-11. PubMed ID: 19946325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC).
    Hollenbach M
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease.
    Yabuuchi J; Ueda S; Yamagishi SI; Nohara N; Nagasawa H; Wakabayashi K; Matsui T; Yuichiro H; Kadoguchi T; Otsuka T; Gohda T; Suzuki Y
    Sci Rep; 2020 Oct; 10(1):17647. PubMed ID: 33077879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic kidney disease and premature ageing.
    Kooman JP; Kotanko P; Schols AM; Shiels PG; Stenvinkel P
    Nat Rev Nephrol; 2014 Dec; 10(12):732-42. PubMed ID: 25287433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycative stress and glyoxalase in kidney disease and aging.
    Inagi R
    Biochem Soc Trans; 2014 Apr; 42(2):457-60. PubMed ID: 24646260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of glycative stress targeting for cancer prevention.
    Piperi C; Adamopoulos C; Papavassiliou AG
    Cancer Lett; 2017 Apr; 390():153-159. PubMed ID: 28111136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mangiferin Upregulates Glyoxalase 1 Through Activation of Nrf2/ARE Signaling in Central Neurons Cultured with High Glucose.
    Liu YW; Cheng YQ; Liu XL; Hao YC; Li Y; Zhu X; Zhang F; Yin XX
    Mol Neurobiol; 2017 Aug; 54(6):4060-4070. PubMed ID: 27318675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of cellular senescence in the progression of chronic kidney disease and the treatment potencies.
    Wang Y; Wang Y; Yang M; Ma X
    Biomed Pharmacother; 2021 Mar; 135():111191. PubMed ID: 33418306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AGE-RAGE pathway and its relation to cardiovascular disease in patients with chronic kidney disease.
    Leurs P; Lindholm B
    Arch Med Res; 2013 Nov; 44(8):601-10. PubMed ID: 24231387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dicarbonyls induce senescence of human vascular endothelial cells.
    Navarrete Santos A; Jacobs K; Simm A; Glaubitz N; Horstkorte R; Hofmann B
    Mech Ageing Dev; 2017 Sep; 166():24-32. PubMed ID: 28780382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary Advanced Glycation End Products and Risk Factors for Chronic Disease: A Systematic Review of Randomised Controlled Trials.
    Clarke RE; Dordevic AL; Tan SM; Ryan L; Coughlan MT
    Nutrients; 2016 Mar; 8(3):125. PubMed ID: 26938557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.